Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer

被引:136
作者
Galvan, J. A. [1 ]
Zlobec, I. [1 ]
Wartenberg, M. [1 ,2 ]
Lugli, A. [1 ,2 ]
Gloor, B. [3 ]
Perren, A. [1 ,2 ]
Karamitopoulou, E. [1 ,2 ]
机构
[1] Univ Bern, Inst Pathol, Translat Res Unit, CH-3010 Bern, Switzerland
[2] Univ Bern, Inst Pathol, Div Clin Pathol, CH-3010 Bern, Switzerland
[3] Inselspital Bern, Dept Visceral Surg, CH-3010 Bern, Switzerland
关键词
epithelial-mesenchymal transition; tumour budding; tumour-stroma; tumour microenvironment; ZEB1; ZEB2; EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; STEM-CELLS; BETA-CATENIN; COLON-CANCER; HIGH-RISK; TGF-BETA; STAGE-II; CARCINOMA; MARKER;
D O I
10.1038/bjc.2015.177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is evidence that tumour-stroma interactions have a major role in the neoplastic progression of pancreatic ductal adenocarcinoma (PDAC). Tumour budding is thought to reflect the process of epithelial-mesenchymal transition (EMT); however, the relationship between tumour buds and EMT remains unclear. Here we characterize the tumour-budding-and stromal cells in PDAC at protein and mRNA levels concerning factors involved in EMT. Methods: mRNA in situ hybridisation and immunostaining for E-cadherin, beta-catenin, SNAIL1, ZEB1, ZEB2, N-cadherin and TWIST1 were assessed in the main tumour, tumour buds and tumour stroma on multipunch tissue microarrays from 120 well-characterised PDACs and associated with the clinicopathological features, including peritumoural (PTB) and intratumoural (ITB) budding. Results: Tumour-budding cells showed increased levels of ZEB1 (Po0.0001) and ZEB2 (P = 0.0119) and reduced E-cadherin and b-catenin (P<0.0001, each) compared with the main tumour. Loss of membranous beta-catenin in the main tumour (P = 0.0009) and tumour buds (P = 0.0053), without nuclear translocation, as well as increased SNAIL1 in tumour and stromal cells (P = 0.0002, each) correlated with high PTB. ZEB1 overexpression in the main tumour-budding and stromal cells was associated with high ITB (P = 0.0084; 0.0250 and 0.0029, respectively) and high PTB (P = 0.0005; 0.0392 and 0.0007, respectively). ZEB2 overexpression in stromal cells correlated with higher pT stage (P = 0.03), lymphatic invasion (P = 0.0172) and lymph node metastasis (P = 0.0152). Conclusions: In the tumour microenvironment of phenotypically aggressive PDAC, tumour-budding cells express EMT hallmarks at protein and mRNA levels underlining their EMT-type character and are surrounded by stromal cells expressing high levels of the E-cadherin repressors ZEB1, ZEB2 and SNAIL1, this being strongly associated with the tumour-budding phenotype. Moreover, our findings suggest the existence of subtypes of stromal cells in PDAC with phenotypical and functional heterogeneity.
引用
收藏
页码:1944 / 1950
页数:7
相关论文
共 36 条
[1]   A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment [J].
Apte, Minoti V. ;
Wilson, Jeremy S. ;
Lugea, Aurelia ;
Pandol, Stephen J. .
GASTROENTEROLOGY, 2013, 144 (06) :1210-1219
[2]   WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma [J].
Arensman, M. D. ;
Kovochich, A. N. ;
Kulikauskas, R. M. ;
Lay, A. R. ;
Yang, P-T ;
Li, X. ;
Donahue, T. ;
Major, M. B. ;
Moon, R. T. ;
Chien, A. J. ;
Dawson, D. W. .
ONCOGENE, 2014, 33 (07) :899-908
[3]   Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer [J].
Arumugam, Thiruvengadam ;
Ramachandran, Vijaya ;
Fournier, Keith F. ;
Wang, Huamin ;
Marquis, Lauren ;
Abbruzzese, James L. ;
Gallick, Gary E. ;
Logsdon, Craig D. ;
McConkey, David J. ;
Choi, Woonyoung .
CANCER RESEARCH, 2009, 69 (14) :5820-5828
[4]   Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface [J].
Bronsert, P. ;
Enderle-Ammour, K. ;
Bader, M. ;
Timme, S. ;
Kuehs, M. ;
Csanadi, A. ;
Kayser, G. ;
Kohler, I. ;
Bausch, D. ;
Hoeppner, J. ;
Hopt, U. T. ;
Keck, T. ;
Stickeler, E. ;
Passlick, B. ;
Schilling, O. ;
Reiss, C. P. ;
Vashist, Y. ;
Brabletz, T. ;
Berger, J. ;
Lotz, J. ;
Olesch, J. ;
Werner, M. ;
Wellner, U. F. .
JOURNAL OF PATHOLOGY, 2014, 234 (03) :410-422
[5]   Presence of Twist1-Positive Neoplastic Cells in the Stroma of Chromosome-Unstable Colorectal Tumors [J].
Celesti, Giuseppe ;
Di Caro, Giuseppe ;
Bianchi, Paolo ;
Grizzi, Fabio ;
Basso, Gianluca ;
Marchesi, Federica ;
Doni, Andrea ;
Marra, Giancarlo ;
Roncalli, Massimo ;
Mantovani, Alberto ;
Malesci, Alberto ;
Laghi, Luigi .
GASTROENTEROLOGY, 2013, 145 (03) :647-+
[6]   Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT) From cancer stem cells to aging-associated fibrosis [J].
Cufi, Silvia ;
Vazquez-Martin, Alejandro ;
Oliveras-Ferraros, Cristina ;
Martin-Castillo, Begona ;
Joven, Jorge ;
Menendez, Javier A. .
CELL CYCLE, 2010, 9 (22) :4461-4468
[7]  
Ellenrieder V, 2001, CANCER RES, V61, P4222
[8]  
Fernandez-del-Castillo C, 2013, SURG TREATMENT EXOCR
[9]   Expression of Snail protein in tumor-stroma interface [J].
Franci, C. ;
Takkunen, M. ;
Dave, N. ;
Alameda, F. ;
Gomez, S. ;
Rodriguez, R. ;
Escriva, M. ;
Montserrat-Sentis, B. ;
Baro, T. ;
Garrido, M. ;
Bonilla, F. ;
Virtanen, I. ;
Garcia de Herreros, A. .
ONCOGENE, 2006, 25 (37) :5134-5144
[10]   TUMOR-CELL DISSOCIATION AT THE INVASION FRONT - A NEW PROGNOSTIC PARAMETER IN GASTRIC-CANCER PATIENTS [J].
GABBERT, HE ;
MEIER, S ;
GERHARZ, CD ;
HOMMEL, G .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (02) :202-207